| Differential roles of STAT3 in the initiation and growth of lung cancer J Zhou, Z Qu, S Yan, F Sun, JA Whitsett, SD Shapiro, G Xiao Oncogene 34 (29), 3804-3814, 2015 | 74 | 2015 |
| Myeloid STAT3 promotes lung tumorigenesis by transforming tumor immunosurveillance into tumor-promoting inflammation J Zhou, Z Qu, F Sun, L Han, L Li, S Yan, LP Stabile, LF Chen, JM Siegfried, ... Cancer Immunology Research 5 (3), 257-268, 2017 | 73 | 2017 |
| Comparative effectiveness of opioid tapering or abrupt discontinuation vs no dosage change for opioid overdose or suicide for patients receiving stable long-term opioid therapy MR Larochelle, S Lodi, S Yan, BA Clothier, ES Goldsmith, ASB Bohnert JAMA network open 5 (8), e2226523-e2226523, 2022 | 29 | 2022 |
| Characteristics of post-overdose public health-public safety outreach in Massachusetts SW Formica, KM Waye, AO Benintendi, S Yan, SM Bagley, L Beletsky, ... Drug and alcohol dependence 219, 108499, 2021 | 24 | 2021 |
| Warrant checking practices by post-overdose outreach programs in Massachusetts: a mixed-methods study ME Tori, E Cummins, L Beletsky, SF Schoenberger, AM Lambert, S Yan, ... International journal of drug policy 100, 103483, 2022 | 18 | 2022 |
| Association of Implementation of Postoverdose Outreach Programs with subsequent opioid overdose deaths among Massachusetts municipalities Z Xuan, S Yan, SW Formica, TC Green, L Beletsky, D Rosenbloom, ... JAMA psychiatry 80 (5), 468-477, 2023 | 15 | 2023 |
| Broadening access to naloxone: community predictors of standing order naloxone distribution in Massachusetts A Chatterjee, S Yan, Z Xuan, KM Waye, AM Lambert, TC Green, ... Drug and alcohol dependence 230, 109190, 2022 | 15 | 2022 |
| Northeast Postacute Medical Facilities Disproportionately Reject Referrals For Patients With Opioid Use Disorder: Study examines post-acute medical facility rejection rates of … SD Kimmel, S Rosenmoss, B Bearnot, Z Weinstein, S Yan, AY Walley, ... Health Affairs 41 (3), 434-444, 2022 | 12 | 2022 |
| Community‐based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island S Nolen, X Zang, A Chatterjee, CN Behrends, TC Green, A Kumar, ... Addiction 117 (5), 1372-1381, 2022 | 9 | 2022 |
| Opioid prescribing patterns among oral and maxillofacial surgeons: a regional survey-based study E Freilich, Y Zhao, S Yan, S Caldroney, P Mehra Journal of Oral and Maxillofacial Surgery 78 (7), 1078-1087, 2020 | 8 | 2020 |
| Do urine drug tests reveal substance misuse among patients prescribed opioids for chronic pain? MR Larochelle, R Cruz, S Kosakowski, DL Gourlay, DP Alford, Z Xuan, ... Journal of general internal medicine 37 (10), 2365-2372, 2022 | 6 | 2022 |
| Characteristics of post-overdose outreach programs and municipal-level opioid overdose in Massachusetts SD Kimmel, Z Xuan, S Yan, AM Lambert, SW Formica, TC Green, ... International Journal of Drug Policy 120, 104164, 2023 | 2 | 2023 |
| Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts SD Kimmel, AY Walley, LF White, S Yan, C Grella, A Majeski, MD Stein, ... JAMA Network Open 7 (7), e2421740-e2421740, 2024 | 1 | 2024 |
| “Wanna cry this out real quick?”: an examination of secondary traumatic stress risk and resilience among post-overdose outreach staff in Massachusetts SF Schoenberger, ER Cummins, JJ Carroll, S Yan, A Lambert, SM Bagley, ... Harm Reduction Journal 21 (1), 66, 2024 | 1 | 2024 |
| Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes BJ Bovell-Ammon, S Yan, D Dunn, EA Evans, PD Friedmann, AY Walley, ... JAMA Network Open 7 (3), e242732-e242732, 2024 | 1 | 2024 |
| Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019 A Chatterjee, S Yan, A Lambert, JR Morgan, TC Green, PJ Jeng, A Jalali, ... Health services research 58 (5), 1141-1150, 2023 | 1 | 2023 |
| Receipt of medications for opioid use disorder before and after incarceration in Massachusetts State prisons, 2014-2019 BJ Bovell-Ammon, S Yan, D Dunn, EA Evans, PD Friedmann, AY Walley, ... Drug and Alcohol Dependence, 111392, 2024 | | 2024 |
| Insurance Instability for Patients With Opioid Use Disorder in the Year After Diagnosis PJ Christine, AL Goldman, JR Morgan, S Yan, A Chatterjee, AL Bettano, ... JAMA Health Forum 5 (7), e242014-e242014, 2024 | | 2024 |
| An Emulated Trial of Buprenorphine-Naloxone Versus Extended-Release Naltrexone Following Medically Managed Opioid Withdrawal M Larochelle, S Yan, P Christine, H Hsu, B Bovell-Ammon, R Puppala, ... Drug and Alcohol Dependence 260, 110511, 2024 | | 2024 |
| Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder PJ Christine, S Lodi, HE Hsu, B Bovell‐Ammon, S Yan, D Bernson, ... Addiction, 2024 | | 2024 |
